Cardiac Biotech Solutions Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBSC research report →
About the company
Operating globally through its international subsidiaries, Cardiac Biotech Solutions Inc. delivers advanced products and services for non-invasive, mobile cardiac monitoring. The company's portfolio includes FDA and CE-approved EKG devices, sophisticated cloud-based data acquisition software, and intuitive smartphone applications compatible with both iOS and Android platforms.
- CEO
- Charles K. Martin
- IPO
- 2016
- Employees
- 5
- HQ
- Las Vegas, CA, US
Price Chart
- Market Cap
- $4.50M
- P/E
- -7.29
- P/S
- 29.49
- P/B
- -2.89
- EV/EBITDA
- -4.35
- Div Yield
- 0.00%
- Gross Margin
- 29.51%
- Op Margin
- -757.45%
- Net Margin
- -594.50%
- ROE
- 42.18%
- ROIC
- 97.10%
- Revenue
- $152.73K · 268.94%
- Net Income
- $-895,973 · 46.69%
- EPS
- $-0.01 · 49.06%
- Op Income
- $-1,156,842
- FCF YoY
- 0.00%
- 52W High
- $0.06
- 52W Low
- $0.02
- 50D MA
- $0.04
- 200D MA
- $0.04
- Beta
- 1.82
- Avg Volume
- 16.92K
Get TickerSpark's AI analysis on CBSC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CBSC coverage
Recent articles, reports, and earnings notes.
No research on CBSC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CBSC report →Similar companies
Peers in the same neighborhood.